All Stories

  1. CDK1 Inhibition Targets the p53-NOXA-MCL1 Axis, Selectively Kills Embryonic Stem Cells, and Prevents Teratoma Formation
  2. 686: microRNAs in hepatocellular carcinoma
  3. Inositol Phosphate Recycling Regulates Glycolytic and Lipid Metabolism That Drives Cancer Aggressiveness
  4. Taking on Challenging Targets: Making MYC Druggable
  5. MicroRNA‐494 within an oncogenic microRNA megacluster regulates G 1 /S transition in liver tumorigenesis through suppression of mutated in colorectal cancer
  6. A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis
  7. Endogenous Nuclear RNAi Mediates Behavioral Adaptation to Odor
  8. Quantitative measurement of cancer metabolism using stimulated echo hyperpolarized carbon-13 MRS
  9. HER3 signalling is regulated through a multitude of redundant mechanisms in HER2-driven tumour cells
  10. Investigating tumor perfusion and metabolism using multiple hyperpolarized 13C compounds: HP001, pyruvate and urea
  11. 13C-Pyruvate Imaging Reveals Alterations in Glycolysis that Precede c-Myc-Induced Tumor Formation and Regression
  12. Switching Cdk2 On or Off with Small Molecules to Reveal Requirements in Human Cell Proliferation
  13. Imaging of blood flow using hyperpolarized [13C]Urea in preclinical cancer models
  14. miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma
  15. 3D compressed sensing for highly accelerated hyperpolarized 13 C MRSI with in vivo applications to transgenic mouse models of cancer
  16. A 3′UTR Pumilio-Binding Element Directs Translational Activation in Olfactory Sensory Neurons
  17. Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer
  18. Anti-Oncomir Suppression of Tumor Phenotypes
  19. Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC
  20. Genetic Approaches to Defining Signaling by the CML-Associated Tyrosine kinase BCR-ABL1
  21. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene
  22. Positive and Negative Growth Effects of Abl Genes
  23. Differential complementation of Bcr-Abl point mutants with c-Myc
  24. RNA Interference (RNAi) With RNase III-Prepared siRNAs